Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor

Archives of Pharmacal Research

Volumn 36, Issue 10, 2013, Pages 1189-1197

  Kim, So Hee ^a   Ha, Young Mi ^b   Moon, Kyoung Mi ^a   Choi, Yeon Ja ^a   Park, Yun Jung ^a   Jeong, Hyoung Oh ^a   Chung, Ki Wung ^a   Lee, Hye Jin ^a   Chun, Pusoon ^c   Moon, Hyung Ryong ^a   Chung, Hae Young ^a  

^a Pusan National University   (South Korea)

^b Dong A University   (South Korea)

^c Inje University   (South Korea)

Author keywords

(Z) 5 (2,4 Dihydroxybenzylidene)thiazolidine 2,4 diones; B16F10 melanoma cells; cAMP; Melanogenesis; PKA; Tyrosinase inhibitor

Indexed keywords

CYCLIC AMP; KOJIC ACID; MHY 498; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; OXYGENASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIMELANOGENIC ACTIVITY; ARTICLE; BINDING AFFINITY; CELL SURVIVAL; CELL VIABILITY; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; ENZYME INHIBITION; HYDROGEN BOND; IC 50; MELANOGENESIS; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN PIGMENTATION; UPREGULATION;

ALPHA-MSH; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; MELANINS; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PYRONES; THIAZOLIDINEDIONES;

EID: 84885958541     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0184-5     Document Type: Article

References (42)

1. Bertolotto, C., P. Abbe, T. Hemesath, K. Bille, D.E. Fisher, J.P. Ortonne, and R. Ballotti. 1998. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. Journal of Cell Biology 142: 827-835.
2. Bilodeau, M.L., J.D. Greulich, R.L. Hullinger, C. Bertolotto, R. Ballotti, and O.M. Andrisani. 2001. BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes. Pigment Cell Research 14: 328-336.
3. Brenner, M., and V.J. Hearing. 2008. The protective role of melanin against UV damage inhuman skin. Photochemistry and Photobiology 84: 539-549.
4. Busca, R., and R. Ballotti. 2000. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Research 13: 60-69.
5. Cabanes, J., S. Chazarra, and F. Garcia-Carmona. 1994. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. Journal of Pharmacy and Pharmacology 46: 982-985.
6. Cacic, M., and M. Molnar. 2011. Design, synthesis and characterization of some novel 3-coumarinyl-5-aryliden-1,3-thiazolidine-2,4-diones and their antioxidant activity. Zeitschrift für Naturforschung 66: 177-183.
7. Choi, H., S. Ahn, B.G. Lee, I. Chang, and J.S. Hwang. 2005. Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling. Pigment Cell Research 18: 439-446.
8. Chung, K.W., Y.J. Park, Y.J. Choi, M.H. Park, Y.M. Ha, Y. Uehara, J.H. Yoon, P.S. Chun, H.R. Moon, and H.Y. Chung. 2012. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4-dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP). Biochimica et Biophysica Acta 1820: 962-969.
9. Ebanks, J.P., R.R. Wickett, and R.E. Boissy. 2009. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. International Journal of Molecular Sciences 10: 4066-4087.
10. Fitzpatrick, T.B. 1971. The biology of pigmentation. Birth Defects Orig Artic Ser 7: 5-12.
11. Garcia, A., and J.E. Fulton Jr. 1996. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatologic Surgery 22: 443-447.
12. Gasperini, S., L. Crepaldi, F. Calzetti, L. Gatto, C. Berlato, F. Bazzoni, A. Yoshimura, and M.A. Cassatella. 2002. Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. European Cytokine Network 13: 47-53.
13. Ha, Y.M., J.A. Kim, Y.J. Park, D.E. Park, Y.J. Choi, J.M. Kim, K.W. Chung, Y.K. Han, J.Y. Park, J.Y. Lee, H.R. Moon, and H.Y. Chung. 2011a. Synthesis and biological activity of hydroxybenzylidenyl pyrrolidine-2,5-dione derivatives as new potent inhibitors of tyrosinase. MedChemComm 2: 542-549.
14. Ha, Y.M., J.A. Kim, Y.J. Park, D.E. Park, J.M. Kim, K.W. Chung, E.K. Lee, J.Y. Park, J.Y. Lee, H.J. Lee, J.H. Yoon, H.R. Moon, and H.Y. Chung. 2011b. Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation. Biochimica et Biophysica Acta 1810: 612-619.
15. Ha, Y.M., J.Y. Park, Y.J. Park, D.E. Park, Y.J. Choi, J.M. Kim, E.K. Lee, Y.K. Han, J.A. Kim, J.Y. Lee, H.R. Moon, and H.Y. Chung. 2011c. Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells. Bioorganic and Medicinal Chemistry Letters 21: 2445-2449.
16. Ha, Y.M., Y.J. Park, J.A. Kim, D.E. Park, J.Y. Park, H.J. Lee, J.Y. Lee, H.R. Moon, and H.Y. Chung. 2012a. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors. European Journal of Medicinal Chemistry 49: 245-252.
17. Ha, Y.M., Y.J. Park, J.Y. Lee, D.E. Park, Y.J. Choi, E.K. Lee, J.M. Kim, J.A. Kim, J.Y. Park, H.J. Lee, H.R. Moon, and H.Y. Chung. 2012b. Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4- carboxylic acid derivatives as novel tyrosinase inhibitors. Biochimie 94: 533-540.
18. Han, Y.K., Y.J. Park, Y.M. Ha, D. Park, J.Y. Lee, N. Lee, J.H. Yoon, H.R. Moon, and H.Y. Chung. 2012. Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384). Biochimica et Biophysica Acta 1820: 542-549.
19. Hermanns, J.F., L. Petit, C. Pierard-Franchimont, P. Paquet, and G.E. Pierard. 2002. Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology 204: 281-286.
20. Im, S., J. Kim, W.Y. On, and W.H. Kang. 2002. Increased expression of alpha-melanocyte stimulating hormone in the lesional skin of melasma. British Journal of Dermatology 46: 165-167.
21. Jiang, H., J. Ding, H. Li, H. Xie, X. Liu, L. Tong, and Y. Xu. 2011. Use of 5-substituted-2,4-thiazolidinediones in preparation of medicaments for modulating insulin-like growth factor 1 receptor. PCT International Applications.
22. Jones, K., J. Hughes, M. Hong, Q. Jia, and S. Orndorff. 2002. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Research 15: 335-340.
23. Kameyama, K., C. Sakai, S. Kondoh, K. Yonemoto, S. Nishiyama, Tagawa, M. Murata, T. Ohnuma, T.J. Quigley, A. Dorsky, D. Bucks, and K. Blanock. 1996. Inhibitory effect of magnesium l-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. Journal of the American Academy of Dermatology 34: 29-33.
24. Kim, Y.J., J.K. No, J.S. Lee, M.S. Kim, and H.Y. Chung. 2006. Antimelanogenic activity of 3,4-dihydroxyacetophenone: inhibition of tyrosinase and MITF. Bioscience Biotechnology and Biochemistry 70: 532-534.
25. Kim, Y.M., J. Yun, C.K. Lee, H. Lee, K.R. Min, and Y. Kim. 2002. Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. Journal of Biological Chemistry 277: 16340-16344.
26. Mauban, J.R., M. O'Donnell, S. Warrier, S. Manni, and M. Bond. 2009. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda) 24: 78-87.
27. Morris, G.M., R. Huey, R.W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson. 2009. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry 30: 2785-2791.
28. Moustakas, D.T., P.T. Lang, S. Pegg, E. Pettersen, I.D. Kuntz, N. Brooijmans, and R.C. Rizzo. 2006. Development and validation of a modular, extensible docking program: DOCK 5. Journal of Computer-Aided Molecular Design 20: 601-619.
29. Nakajima, M., I. Shinoda, Y. Fukuwatari, and H. Hayasawa. 1998. Arbutin increases the pigmentation of cultured human melanocytes through mechanisms other than the induction of tyrosinase activity. Pigment Cell Research 11: 12-17.
30. No, J.K., M.S. Kim, Y.J. Kim, S.J. Bae, J.S. Choi, and H.Y. Chung. 2004. Inhibition of tyrosinase by protocatechuic aldehyde. American Journal of Chinese Medicine 32: 97-103.
31. No, J.K., Y.J. Kim, J.S. Lee, and H.Y. Chung. 2006. Inhibition of melanogenic activity by 4,4′-dihydroxybiphenyl in melanoma cells. Biological and Pharmaceutical Bulletin 29: 14-16.
32. No, J.K., D.Y. Soung, Y.J. Kim, K.H. Shim, Y.S. Jun, S.H. Rhee, T. Yokozawa, and H.Y. Chung. 1999. Inhibition of tyrosinase by green tea components. Life Science 65: PL241-PL246.
33. Ohguchi, K., T. Tanaka, I. Iliya, T. Ito, M. Iinuma, K. Matsumoto, Y. Akao, and Y. Nozawa. 2003a. Gnetol as a potent tyrosinase inhibitor from genus Gnetum. Bioscience Biotechnology and Biochemistry 67: 663-665.
34. Ohguchi, K., T. Tanaka, T. Ito, M. Iinuma, K. Matsumoto, Y. Akao, and Y. Nozawa. 2003b. Inhibitory effects of resveratrol derivatives from dipterocarpaceae plants on tyrosinase activity. Bioscience Biotechnology and Biochemistry 67: 1587-1589.
35. Picardo, M., V. Maresca, L. Eibenschutz, C. De Bernardo, R. Rinaldi, and P. Grammatico. 1999. Correlation between antioxidants and phototypes in melanocytes cultures. A possible link of physiologic and pathologic relevance. The Journal of Investigative Dermatology 113: 424-425.
36. Roh, J.S., J.Y. Han, J.H. Kim, and J.K. Hwang. 2004. Inhibitory effects of active compounds isolated from safflower (Carthamustinctorius L.) seeds for melanogenesis. Biological and Pharmaceutical Bulletin 27: 1976-1978.
37. Shah, S., and B. Singh. 2012. Urea/thiourea catalyzed, solvent-free synthesis of 5-arylidenethiazolidine-2,4-diones and 5-arylidene-2- thioxothiazolidin-4-ones. Bioorganic and Medicinal Chemistry Letters 22: 5388-5391.
38. Shin, N.H., S.Y. Ryu, E.J. Choi, S.H. Kang, I.M. Chang, K.R. Min, and Y.S. Kim. 1998. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochemical and Biophysical Research Communications 243: 801-803.
39. Tada, H., O. Shiho, K. Kuroshima, M. Koyama, and K. Tsukamoto. 1986. An improved colorimetric assay for interleukin 2. Journal of Immunological Methods 93: 157-165.
40. Tomasić, T., N. Zidar, A. Kovac, S. Turk, M. Simcic, D. Blanot, M. Müller-Premru, M. Filipic, S.G. Grdadolnik, A. Zega, M. Anderluh, S. Gobec, D. Kikelj, and L. Peterlin Masic. 2010. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial mur ligases. ChemMedChem 5: 286-295.
41. Yang, Y.M., Y.O. Son, S.A. Lee, Y.M. Jeon, and J.C. Lee. 2011. Quercetin inhibits α-MSH-stimulated melanogenesis in B16F10 melanoma cells. Phytotherapy Research 25: 1166-1173.
42. Yoshimura, K., K. Tsukamoto, M. Okazaki, V.M. Virador, T.C. Lei, Y. Suzuki, G. Uchida, Y. Kitano, and K. Harii. 2001. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. Journal of Dermatological Science 27: S68-S75.